Skip to main content

Table 1 Demographic and clinical characteristics (N = 40)

From: Changes in functional brain networks and neurocognitive function in Chinese gynecological cancer patients after chemotherapy: a prospective longitudinal study

Variables

n (%)

Cancer patients (n = 20)

Healthy controls (n = 20)

Age (years) Mean (SD)

47.15 (9.80) (28–60)

48.60 (6.80) (29–59)

Highest education

 Primary school or below

14 (70.0)

19 (95.0)

 High school

4 (20.0)

1 (5.0)

 University and above

2 (10.0)

 

Employment status

 Employed

1 (5.0)

20 (100)

 Unemployed

19 (95.0)

 

Marital status

 Never married

2 (10.0)

1 (5.0)

 Married

18 (90.0)

18 (90.0)

 Divorced

0 (0.0)

1 (5.0)

Menopausal status

 Pre-menopausal

11 (55.0)

12 (60.0)

 Peri-menopausal

8 (40.0)

7 (35.0)

 Post-menopausal

1 (5.0)

1 (5.0)

Cancer type

 Cervical cancer

8 (40.0)

 

 Ovarian cancer

5 (25.0)

 

 Uterine cancer

7 (35.0)

 

Disease stage

 Stage I-IIa

7 (35.0)

 

 Stage IIb-IIIa

8 (40.0)

 

 Stage IIIb

5 (25.0)

 

Treatment type

 Surgery + Chemotherapya

14 (70.0)

 

 Surgery + Chemotherapya + Radiation

6 (30.0)

 
  1. aChemotherapy regimens including Paclitaxel (TAXOL) with Carboplatin (CBP) or Cisplatin (DDP) or with both; CBP with Doxorubicin (ADM) or TAXOL with ADM; Bleomycin with Methotrexate (MTX) or MTX with DDP